You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 7, July 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Genetics, Other
 •Alert me on articles by topic

Leukoaraiosis

Reifying Rarefaction

Arch Neurol. 2000;57:925-926.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MEDICAL TERMS sometimes acquire a life of their own. The term leukoaraiosis (LA) was coined to avoid presumptions about etiology and neuropathology of a radiological phenomenon—white matter rarefaction found first on computed tomographic scans and later more profusely on magnetic resonance images.1 It was to be a

neutral term, exact enough to define white matter changes in the elderly or the demented, general enough that it serves as a description and a label, and demanding enough that it calls for a precise clinical and imaging description accompanied when possible by pathologic confirmation.1

The intention was that as the significance of the lesions became clear, a more precise and clinically relevant nomenclature would be developed. However, the term has gained acceptance as an entity, the concept having been undeservedly reified.

This is reflected in the contradictory nature of several reports in the abundant literature related to white matter changes (WMCs) that . . . [Full Text of this Article]


RELATED ARTICLE

What Is the Significance of Leukoaraiosis in Patients With Acute Ischemic Stroke?
Malgorzata Wiszniewska, Gérald Devuyst, Julien Bogousslavsky, Joseph Ghika, and Guy van Melle
Arch Neurol. 2000;57(7):967-973.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of White Matter Hyperintensity Volume With Decreased Cognitive Functioning: The Framingham Heart Study
Au et al.
Arch Neurol 2006;63:246-250.
ABSTRACT | FULL TEXT  

Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study
Jeerakathil et al.
Stroke 2004;35:1857-1861.
ABSTRACT | FULL TEXT  

White matter disease and sleep-disordered breathing after acute stroke
Harbison et al.
Neurology 2003;61:959-963.
ABSTRACT | FULL TEXT  

Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease
Hogervorst et al.
Arch Neurol 2002;59:787-793.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.